Brazil's Haddad awaits 'final information' on Petrobras dividend decision-March 2024-www.financetom.com

Brazil's Haddad awaits 'final information' on Petrobras dividend decision

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Brazil's Haddad awaits 'final information' on Petrobras dividend decision

Apr 3, 2024 3:03 PM

BRASILIA, April 3 (Reuters) - Brazil's Finance Minister,

Fernando Haddad, said on Wednesday that the government is

waiting for "final information" that will be taken to the board

of directors of state-run oil firm Petrobras for its

decision on the company's dividends and investments.

The minister told reporters that Petrobras' investment plan

was discussed in a meeting with the government's chief of staff.

Previous page： Adventus Mining Says Key Authorization for El Domo-Curipamba Project in Ecuador Facing Legal Challenge Next page： Marinus Pharmaceuticals Epilepsy Treatment Falls Short in Phase 3 Study

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Adventus Mining Says Key Authorization for El Domo-Curipamba Project in Ecuador Facing Legal Challenge

Jun 17, 2024

08:06 AM EDT, 06/17/2024 (MT Newswires) -- Adventus Mining ( ADVZF ) and Salazar Resources (SRL.V) on Monday said a previously obtained key authorization for the El Domo-Curipamba project is being challenged in the Ecuadorian courts. Adventus obtained the environmental license for the mine's construction and operation phase on January 19 from the Ministry of Environment, Water, and Ecological Transition...

Marinus Pharmaceuticals Epilepsy Treatment Falls Short in Phase 3 Study

Jun 17, 2024

08:03 AM EDT, 06/17/2024 (MT Newswires) -- Marinus Pharmaceuticals ( MRNS ) said on Monday that its experimental drug, intravenous ganaxolone, aimed at treating refractory status epilepticus - a condition where seizures persist despite standard treatments - did not achieve one of its primary goals in a Phase 3 study, sending shares down by 8.5% in premarket trading. Marinus said...

Top Premarket Decliners

Jun 17, 2024

08:02 AM EDT, 06/17/2024 (MT Newswires) -- Ovid Therapeutics ( OVID ) shares slumped 64% Monday premarket after the company said that phase 3 studies conducted by Takeda evaluating Soticlestat in certain types of epilepsy missed their primary endpoints. Kaival Brands Innovations Group ( KAVL ) shares fell 35%, paring Friday's rally. La Rosa Holdings ( LRHC ) shares retreated...

Shake Shack Names Stephanie Sentell Chief Operations Officer

Jun 17, 2024

08:06 AM EDT, 06/17/2024 (MT Newswires) -- Shake Shack ( SHAK ) said Monday it has named Stephanie Sentell as chief operations officer, effective July 1. Sentell was most recently senior vice president of company operations at Inspire Brands, Shake Shack ( SHAK ) said. ...